Which has grown faster, ABCL or ACAD?

Over the past five years, ACAD grew revenue faster — ABCL at a -31.78% CAGR versus ACAD at 19.70%.

Is ABCL or ACAD more profitable?

ACAD runs the higher net margin — ABCL at -248.83% versus ACAD at 33.42%.

How have ABCL and ACAD total returns compared?

Over the past 5 years, ABCL delivered -3.57% and ACAD delivered 3.52% annualized total return. Past performance doesn't predict future results.

AbCellera Biologics Inc. (ABCL) vs Acadia Pharmaceuticals Inc. (ACAD)

A side-by-side comparison of AbCellera Biologics Inc. and Acadia Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABCL

AbCellera Biologics Inc.

$4.21B

$13.78HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

ACAD

Acadia Pharmaceuticals Inc.

$3.44B

$20.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ABCL vs ACAD

growth of $100 · dividends reinvested · last 6y

ABCL -76.6% (-21.5%/yr)ACAD -61.7% (-14.8%/yr)ACAD compounded faster over this window

ABCL ACAD

ABCL vs ACAD: by the numbers

•ABCL is the larger company ($4.21B vs $3.44B market cap).
•ACAD is profitable (33.42% net margin) while ABCL runs a net loss (-248.83%).
•ACAD grew revenue faster over the past five years (19.70% vs -31.78% CAGR).

Metrics side by side

Valuation

Metric	ABCL	ACAD
P/E ratio	N/A	9.06
Forward P/E	N/A	32.65
P/S ratio	63.59	3.02
P/B ratio	4.70	2.64
EV / EBITDA	N/A	31.84
FCF yield	N/A	5.06%

Profitability

Metric	ABCL	ACAD
Gross margin	61.64%	91.13%
Operating margin	-288.98%	7.59%
Net margin	-248.83%	33.42%
ROE	-18.38%	29.12%
ROIC	-17.95%	6.25%

Growth (annualized)

Metric	ABCL	ACAD
Revenue CAGR (5Y)	-31.78%	19.70%
Total return CAGR (5Y)	-3.57%	3.52%

Frequently asked

Which has grown faster, ABCL or ACAD?: Over the past five years, ACAD grew revenue faster — ABCL at a -31.78% CAGR versus ACAD at 19.70%.
Is ABCL or ACAD more profitable?: ACAD runs the higher net margin — ABCL at -248.83% versus ACAD at 33.42%.
How have ABCL and ACAD total returns compared?: Over the past 5 years, ABCL delivered -3.57% and ACAD delivered 3.52% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABCL analysis Full ACAD analysis Interactive comparison tool

Dig into the metrics

Acadia Pharmaceuticals P/E ratio AbCellera Biologics ROE Acadia Pharmaceuticals ROE AbCellera Biologics operating margin Acadia Pharmaceuticals operating margin AbCellera Biologics revenue growth Acadia Pharmaceuticals revenue growth AbCellera Biologics free cash flow Acadia Pharmaceuticals free cash flow

AbCellera Biologics & Acadia Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.